PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'From the Assistant Professor, Division of General Internal Medicine and Geriatrics, Section of Addiction Medicine, Oregon Health and Science University, Portland, OR; Associate Professor, Division of Hospital Medicine, Section of Addiction Medicine, Oregon Health and Science University, Portland, OR; and Associate Professor, Division of General Internal Medicine and Geriatrics, Section of Addiction Medicine, Oregon Health and Science University, Portland, OR. robbijon@ohsu.edu.\', \'From the Assistant Professor, Division of General Internal Medicine and Geriatrics, Section of Addiction Medicine, Oregon Health and Science University, Portland, OR; Associate Professor, Division of Hospital Medicine, Section of Addiction Medicine, Oregon Health and Science University, Portland, OR; and Associate Professor, Division of General Internal Medicine and Geriatrics, Section of Addiction Medicine, Oregon Health and Science University, Portland, OR.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3122/jabfm.2021.S1.200236
?:hasPublicationType
?:journal
  • Journal of the American Board of Family Medicine : JABFM
is ?:pmid of
?:pmid
?:pmid
  • 33622829
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Buprenorphine Microdose Induction for the Management of Prescription Opioid Dependence.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all